Global Iron Sucrose Injection Market Size To Exceed USD 5.66 Billion By 2035 | CAGR of 7.14%
Category: HealthcareGlobal Iron Sucrose Injection Market Size To Exceed USD 5.66 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Iron Sucrose Injection Market Size is expected to grow from USD 2.65 Billion in 2024 to USD 5.66 Billion by 2035, at a CAGR of 7.14% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global Iron Sucrose Injection Market Size, Share, and COVID-19 Impact Analysis, By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Chemotherapy-Induced Anemia, and Others), By End-user (Hospitals, Out-patient Infusion & Oncology Centers, Dialysis Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. " Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/iron-sucrose-injection-market
The iron sucrose injection market is an industry that emphasises the production, distribution, and sale of iron sucrose, a product used for intravenous iron replacement in the treatment of iron deficiency anaemia, particularly in patients with chronic kidney disease. Iron sucrose, also known as Venofer, is an iron replacement product used to treat iron deficiency anaemia. There are increasing advancements in drug delivery technologies like nanoparticle-based formulations for improving iron absorption with reduced side effects. An increasing adoption of personalised medicine, which encourages manufacturers to develop targeted and effective drug formulations, is bolstering the market opportunities. The increasing prevalence of iron deficient anemia, surging need for effective intravenous iron treatments, and improvement in healthcare infrastructure are driving the iron sucrose injection market. On the contrary, competition from alternative oral formulations and potential adverse effects of IV iron sucrose injection are challenging the market growth.
The chronic kidney diseases segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the application, the iron sucrose injection market is divided into chronic kidney disease, inflammatory bowel disease, chemotherapy-induced anemia, and others. Among these, the chronic kidney diseases segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Iron deficiency anemia is commonly associated with chronic diseases, including chronic kidney disease (CKD), where erythropoietin production is decreased. Thus, the increasing prevalence of CKD, with increased diabetes and hypertension cases, is supporting the market demand.
The hospitals segment dominated the iron sucrose injection market in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end-user, the iron sucrose injection market is divided into hospitals, out-patient infusion & oncology centers, dialysis centers, and others. Among these, the hospitals segment dominated the iron sucrose injection market in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. In hospitals, iron sucrose injection is used for the rapid treatment of iron deficiency anemia by replenishing the body’s iron stores. An increasing number of hospital admissions and prevalence of anaemia-related disorders are driving the market in the hospitals segment.
North America is expected to hold the majority share of the global iron sucrose injection market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global iron sucrose injection market during the forecast period. The increasing number of approvals and launch of new IV drugs, as well as quicker and more effective iron replacement provided by these drugs, are driving the market. Favourable regulatory policies for approval of new generic versions, along with an ongoing expansion of affordable genetic options, are supporting the market growth of iron sucrose injection.
Asia Pacific is anticipated to grow at the fastest pace in the global iron sucrose injection market during the forecast period. The increasing prevalence of chronic diseases like CKD, IBD, and cancer is responsible for driving the iron sucrose injection market demand. Government support for enabling treatment accessibility with increased healthcare expenditure is promoting the market growth.
Major vendors in the global iron sucrose injection market are Daiichi Sankyo, Alkem Laboratories, Alembic Pharmaceuticals Ltd., Emcure Pharma, Pfizer Inc., Sanofi S.A., Fresenius Medical Care AG & Co. KGaA, American Regent, Inc., Vifor Pharma Group, Pharmacosmos A/S, Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Watson Pharmaceuticals, Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2025, Sandoz, the global leader in affordable medicines, announced the US launch of its generic iron sucrose injection following recent approval by the USFDA.
- In August 2025, Viatris Inc., a global healthcare company, announced the USFDA had approved iron sucrose injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia (IDA) in adult and pediatric patients with chronic kidney disease (CKD).
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the iron sucrose injection market based on the below-mentioned segments:
Global Iron Sucrose Injection Market, By Application
- Chronic Kidney Disease
- Inflammatory Bowel Disease
- Chemotherapy-Induced Anemia
- Others
Global Iron Sucrose Injection Market, By End-user
- Hospitals
- Out-patient Infusion & Oncology Centers
- Dialysis Centers
- Others
Global Iron Sucrose Injection Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?